跳转到主要内容
搜索

监管审批

注册

最新资源

精选资源

Upcoming regulatory webinars

Latest regulatory blogs

在以下活动中与我们的专家会面

会议

ASCPT 2026 Annual Meeting

March 4 - 6, 2026 – Denver, CO
会议

ACDM 2026

March 15 - 17, 2026 – Berlin, Germany – Booth 13
会议

Phuse US Connect 2026

March 23 - 25, 2026 – Austin, TX, USA

All regulatory resources

FAQs: The ICH M15 Guideline and What It Means for Model-Informed Drug Development

Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Pediatric Drug Development: From “Wild West” to Model-Informed Confidence

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Pharmacometrics, Blog

Ready for ESG NextGen, or still submitting like it’s 2015?

Certara Products, Certara Products - GlobalSubmit, Webinar

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Infectious Disease, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Pediatrics, Therapeutic Specialties, Publication

Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach

Certara Services, Drug Development, Rare and Neglected Diseases, Therapeutic Specialties, Press Coverage

P21 Enterprise Expands Regulatory Validation Capabilities with Support for the Tobacco Implementation Guide v1.0

CDISC, Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Drug Development, Blog

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Webinar

Certara 革新药物研发解决方案：长效变革，普惠未来

事实资料表

CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access

Biologics, Certara Products, Certara Products - Certara IQ, Certara Products - Phoenix, Certara Products - Simcyp, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

监管前沿：全球战略洞察与 2026 展望，来自主要监管机构前任领导者的洞见

Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, On-Demand Webinar

Fierce BIO

会议

Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Pharmacometrics, Blog
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software